In prostate cancer cell lines, Zhu and colleagues [130] have shown that p53 regulates EMMPRIN (extracellular matrix metalloproteinase inducer), an N-glycosylated plasma membrane protein upregulated in different tumor types. The gene discussed is TP53; the disease is neoplasm.